Introduction: It is recognised that osteocytes, by secreting sclerostin plays a more central role in bone homeostasis. Sclerostin is a physiological inhibitor of bone formation. By binding to the LRP5/6 receptor sclerostin inhibits the Wnt signalling pathway. A cross-sectional study was undertaken to ascertain whether an endogenous sclerostin circadian rhythm exists in healthy individuals.
Subjects and methods: Six healthy young men with normal BMD were admitted overnight. Blood samples were drawn every hour for 24 h samples obtained centrifuged immediately. The serum/plasma was separated and frozen at −70 °C for later analysis. An enzyme linked immunoassay (Biomedica, Austria) was used to measure sclerostin. All samples were assayed in duplicates. The inter and intra assay CV% being 12.3 and <5% respectively.
Statistical analysis: CHRONOLAB 3.0 (Universdade de Vigo, Vigo, Spain) a software package validated for analyzing biological time series by least squares estimation was used to analyze individual and population mean cosinor. The following circadian rhythm parameters were evaluated: 1) midline estimate statistic of rhythm (MESOR), 2) amplitude and 3) acrophase. A p value for the rejection of the zero-amplitude (no rhythm) assumption is determined for each individual and for the group.
Results: A definite sclerostin circadian rhythm was identified in the study population (P=0.028). The mean sclerostin (MESOR) was 84.4±1.4 pmol/l. A nocturnal sclerostin peak (time of onset 0100 h) with concentrations remaining above mean over 4 h was observed. A small but ill sustained increase is noted at 0700 h which culminates in a steep descent to a trough (at 0800 h) the levels remain low throughout the morning till midday (1200 h). The maximum percentage increase in the sclerostin concentration between 0100 h and 0700 h ((value at each time point 0100 h value)/ 0100 h value × 100)) was 19.7%.
Conclusion: Our results demonstrate a circadian rhythm with a nocturnal peak in the sclerostin secretion for young healthy men.
27 Apr - 01 May 2013
European Society of Endocrinology